Am J Transplant, Volume 21, Suppl 3 Archives - Page 17 of 139 - ATC Abstracts

2021 American Transplant Congress
Removal of Race Factor in Egfr Decreases Disparities in Preemptive Listing for Kidney Transplantation
Y. Al-Salmay, N. Jandovitz, M. Abate, A. Baez, E. Molmenti, A. Fahmy, N. Breslin, L. Teperman, V. Nair
Organ Transplantation, Northwell Health, Manhasset, NY
*Purpose: GFR < 20 is required for kidney transplant listing. The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD)…
2021 American Transplant Congress
Survey of Transplantation Providers to Assess for Implicit Bias at a Single Center
C. Ramirez-Sanchez¹, A. Cardenas², S. Aslam¹, F. Ferguson², M. Vazquez², T. Magee², K. Mekeel²
¹Infectious Diseases, University of California San Diego, La Jolla, CA, ²University of California San Diego, La Jolla, CA
*Purpose: At our institution’s Center for Transplantation, the Implicit Bias Working Group (IBWG), was formed with the aim to comprehend how implicit biases impact the…
2021 American Transplant Congress
Kidney Transplantation Management and Decision Support System
A. Demirag¹, Y. Wu², J. Lamp², S. Holland¹, A. Routt², L. Feng²
¹Transplantation, University of Virginia Medical Cener, Charlottesville, VA, ²Computer Science Engineering Systems & Environment, University of Virginia, Charlottesville, VA
*Purpose: Coordinating the management of patients’ health statuses, tracking and scheduling testing, is a complicated process and involves a team of clinicians including transplant coordinators,…
2021 American Transplant Congress
Comparative Outcomes of TPIAT in African American and Caucasian Patients with Chronic Pancreatitis
M. A. Kanak, J. B. Spriggs, P. Coughenour, J. Kalivarathan, P. Saravanan, M. F. Levy
Virginia Commonwealth University, Richmond, VA
*Purpose: Total pancreatectomy with islet auto-transplantation (TPIAT) is becoming the standard of care for patients with chronic pancreatitis, as it provides pain relief and improved…
2021 American Transplant Congress
Outcomes of Simultaneous Kidney-Pancreas Transplantation in Patients with Type-I and Type-II Diabetes Mellitus
H. Shokouh-Amiri¹, M. S. Naseer¹, A. Palermini¹, D. Aultman¹, R. McMillan¹, S. Tandukar², N. Singh², G. Zibari¹
¹Advanced Surgery, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, ²Transplant Nephrology, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA
*Purpose: UNOS approved simultaneous kidney-pancreas transplantation (SKPT) for type-II diabetes mellitus (DM) in Oct 2014. There is limited data comparing outcomes of SKPT in type-I…
2021 American Transplant Congress
Dual Liver and Kidney Donors, What Makes Them Decide to Do It?
H. Al Harakeh, B. Emmanuel, C. Hughes, A. Tevar, J. Steel, A. F. DiMartini, S. Ganesh, A. Humar
Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: There is incongruity between the transplant waiting list and the number of deceased donors available, therefore there is an enduring challenge to increase the…
2021 American Transplant Congress
Panic in the Pandemic: A Medical Decision Analysis Examining When Kidney Transplant Programs Should Close
A. J. Vinson¹, B. Kiberd², K. Tennankore¹
¹Nova Scotia Health Authority Division of Nephrology, Departm, Halifax, NS, Canada, ²Dalhousie University, Halifax, NS, Canada
*Purpose: Pandemics greatly interfere with overall health care delivery as resources are diverted to combat the crisis. Kidney transplantation programs were closed temporarily during the…
2021 American Transplant Congress
Elevated Tacrolimus Levels in Hospitalized Organ Transplant Recipients with COVID-19
K. Mecadon¹, A. Hardesty², K. Vieira³, R. Rogers³, B. Merhi⁴, A. J. Osband⁵, G. Bayliss⁴, R. Gohh⁴, P. Morrissey⁵, D. Farmakiotis³
¹Department of Pharmacy, Rhode Island Hospital, Providence, RI, ²Department of Internal Medicine, Residency, Warren Alpert Medical School of Brown University, Providence, RI, ³Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, ⁴Division of Nephrology, Warren Alpert Medical School of Brown University, Providence, RI, ⁵Department of Surgery (Transplantation), Warren Alpert Medical School of Brown University, Providence, RI
*Purpose: The effect of COVID-19 on immunosuppressant drug levels in organ transplant recipients (OTRs) has not been adequately studied.*Methods: We retrospectively studied hospitalized adult (>18-year-old)…
2021 American Transplant Congress
Combined CD11b/CD40 Blockade is Superior to CD40 Blockade Alone in Prolonging Survival in Pig-to-Nonhuman Primate Renal Xenotransplantation
D. A. Faber¹, B. Lovasik¹, A. Matar¹, C. Breeden¹, S. Kim¹, A. Adams²
¹Surgery, Emory University School of Medicine, Atlanta, GA, ²Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Blockade of the CD40/CD154 pathway is highly effective in preventing rejection in pig-to-nonhuman primate (NHP) xenotransplantation models. Clinical translation of anti-CD154 mAbs, however, has…
2021 American Transplant Congress
Peripheral Blood Hematopoietic Chimerism: A Robust Biomarker for Transplantation Tolerance
D. Tollerud¹, E. Gornstein¹, J. Leventhal², K. V. Ravindra³, S. Ildstad¹
¹Talaris Therapeutics, Louisville, KY, ²Division of Organ Transplantation, Northwestern Medical Group, Chicago, IL, ³Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: Despite the development of highly effective immunosuppressive medications, organ rejection and the toxicity of the drugs themselves remain significant obstacles to long-term graft and…